Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
abbvie
3
×
biotech
boston blog main
boston top stories
3
×
clinical trials
3
×
graybug vision
3
×
life sciences
national
national blog main
national top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
anemia
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
gene therapy
glaxosmithkline
indiana blog main
indiana top stories
johnson & johnson
medical devices
new york blog main
new york top stories
pfizer
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wet age-related macular degeneration
wisconsin blog main
wisconsin top stories
10x genomics
What
bio
cancer
days
roundup
abbvie’s
ahead
august
biofourmis
biotech
blood
broader
bucks
busy
celebrate
chance
company
corner
day
decisions
detect
developing
devices
drugs
fda
files
firms
forward
grail
holiday
intended
investors
ipo
join
labor
legacy
life
looking
news
nods
opioid
Language
unset
3
×
Current search:
abbvie
×
unset
×
" boston top stories "
×
" clinical trials "
×
photo
×
" graybug vision "
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
3 years ago
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
